ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Cranial Radiation Eliminated With Personalized Chemo

August 28, 2009

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer

January 8, 1993

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002